Opinion
Video
Clinical Scenario and Perspectives on the Evolving Treatment Landscape in GVHD
Author(s):
Dr. Hannah Choe discusses a clinical scenario of a patient with GVHD who has progressed after multiple lines of treatment. She explores how the availability of CSF-1R inhibitors could fit into the evolving treatment landscape for managing this difficult-to-treat patient population. Dr. Choe provides her perspectives on the potential role and clinical implications of targeting this pathway as an emerging therapeutic approach for GVHD.
EP: 1.Graft-Versus-Host Disease: Pathogenesis, Clinical Challenges, and Unmet Treatment Needs
EP: 2.The CSF-1R Signaling Pathway in GVHD and Investigational Agents Targeting this Pathway
EP: 3.AGAVE-201 Investigating Axatilimab In Recurrent of Refractory cGVHD
Now Viewing
EP: 4.Clinical Scenario and Perspectives on the Evolving Treatment Landscape in GVHD
Related Videos
Related Content
